Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence H Boise

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Blood|October 5, 2019
Myeloma's sound of silencingLawrence H Boise
Blood|June 6, 2015
DUB-ling down on B-cell malignanciesLawrence H Boise
Blood|May 22, 2010
Aiming at WM with both barrels blockedLawrence H Boise
Blood|September 8, 2018
A miRaculous new therapy in myeloma?Lawrence H Boise
Blood|September 27, 2014
To Gli or not to GliLawrence H Boise
Seminars in Oncology|October 19, 2013
The future of drug development and therapy in myelomaSagar Lonial, Lawrence H Boise
Cancer Research|May 3, 2019
Stromal Support of Metabolic Function through Mitochondrial Transfer in Multiple MyelomaLawrence H Boise, Mala Shanmugam
Oncology (Williston Park, N.Y.)|September 5, 2014
Current advances in novel proteasome inhibitor-based approaches to the treatment of relapsed/refractory multiple myelomaSagar Lonial, Lawrence H Boise
Autophagy|January 19, 2011
Farnesyl transferase inhibitors, autophagy, and proteasome inhibition: synergy for all the right reasonsSagar Lonial, Lawrence H Boise
Blood|March 28, 2024
TP53 function over forms in multiple myelomaPaola Neri, Lawrence H Boise
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Blood|October 5, 2019
Myeloma's sound of silencingLawrence H Boise
Blood|June 6, 2015
DUB-ling down on B-cell malignanciesLawrence H Boise
Blood|May 22, 2010
Aiming at WM with both barrels blockedLawrence H Boise
Blood|September 8, 2018
A miRaculous new therapy in myeloma?Lawrence H Boise
Blood|September 27, 2014
To Gli or not to GliLawrence H Boise
Seminars in Oncology|October 19, 2013
The future of drug development and therapy in myelomaSagar Lonial, Lawrence H Boise
Cancer Research|May 3, 2019
Stromal Support of Metabolic Function through Mitochondrial Transfer in Multiple MyelomaLawrence H Boise, Mala Shanmugam
Oncology (Williston Park, N.Y.)|September 5, 2014
Current advances in novel proteasome inhibitor-based approaches to the treatment of relapsed/refractory multiple myelomaSagar Lonial, Lawrence H Boise
Autophagy|January 19, 2011
Farnesyl transferase inhibitors, autophagy, and proteasome inhibition: synergy for all the right reasonsSagar Lonial, Lawrence H Boise
Blood|March 28, 2024
TP53 function over forms in multiple myelomaPaola Neri, Lawrence H Boise
Pageof 14